´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ (¿Â¶óÀÎ) (Virtual Congress) (KCR 2020) The 40th Korean College of Rheumatology Annual Scientific Meeting and 14th International Symposium : 2020-10-22±³À°ÀÏÀÚ : 2020-10-22
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) (Virtual Congress) (KCR 2020) The 40th Korean College of Rheumatology Annual Scientific Meeting and 14th International Symposium ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630
À̸ÞÀÏ :
webmaster@rheum.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 19 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 75,000¿ø
ºñ°í KCR Member -Medical or scientific professionals, clinicians, M.D.s and, Ph.D.s. 60,000 Won (KRW) -Resident and Allied Health Professionals 30,000 Won (KRW) Non-Member -Medical or scientific professionals, clinicians, M.D.s and, Ph.D.s. 75,000 Won (KRW) -Full-time graduate students 40,000 Won (KRW) -Full-time undergraduate students Free of Charge -Industry Personnel 75,000 Won (KRW) -Resident and nurse 40,000 Won (KRW) International -Medical or scientific professionals, clinicians, M.D.s and, Ph.D.s. 75 USD -Resident and Allied Health Professionals 40 USD Full-time undergraduate students Free of Charge (Pre-registration is necessarily required)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 08:00~08:50 Radiographic inhibition of TNF inhibitor on AS and non-radiographic axial SpA Xenofon Baraliakos(Ruhr-Univ. Germany)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 09:00~10:30 Plenary Session - International Free Paper Session ±¸¿¬(¹ßÇ¥ ¼¼¼Ç)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 11:00~11:30 Plasmonic schirmer strip for human tear-based gouty arthritis diagnosis using surface-enhanced raman scattering Ki-Hun Jeong(KAIST Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 11:30~12:00 What is the best choice for urate lowering therapy for Korean? Yun-Hong Cheon(Gyeongsang Nat¡¯l Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 12:00~12:30 Korean guideline for the management of gout Jennifer Jooha Lee(The Catholic Univ. of Korea Kroea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 12:30~13:30 Treat AS to target, and role of IL-17A for AS patients James Wei(Chung Shan Medical University Taiwan)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 13:30~14:00 Radiographic progression: Looking beyond the clinical response Robert Landewe(Amsterdam UMC Netherlands)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 14:00~14:30 HLA-B27 transgenic rats: contributions to understanding the pathogenesis of spondyloarthritis Joel D. Taurog(Univ. of Texas Southwestern Med. Center Belgium)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 14:30~15:00 Clinical status of ankylosing spondylitis in a real world Tae-Hwan Kim(Hanyang Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 16:00~16:30 Drug target discovery for osteoporosis from clinical observation Beom-Jun Kim(Univ. of Ulsan Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 16:30~17:00 RANKL inhibitors effects on muscle and the periosteum Serge Ferrari(Univ. of Geneva Switzerland)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM A 17:00~17:30 Comparative safety of osteoporosis medications Seoyoung Catherine Kim(Harvard Univ. USA)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 08:00~08:50 New treatment option for Ankylosing Spondylitis: Ixekizumab, a new IL-17A inhibitor Min-Chan Park(Yonsei Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 11:00~12:30 Free Paper Session - Epidemiology & Health Service Research ±¸¿¬(¹ßÇ¥ ¼¼¼Ç)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 12:30~13:30 Tofacitinib for the treatment of RA: Key learnings from clinical trial data and real world experience Gordon K. Lam(Northern Region Research Center USA)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 13:30~13:45 Prediction of remission for each biologics based on patient's clinical information before starting biologics using explainable artificial intelligence: data from the KOBIO registry Bon San Koo(Inje Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 13:45~14:00 Clinical efficacy of low-dose infliximab treatment among patients with ankylosing spondylitis Hyoungyoung Kim(Hanyang Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 14:00~14:15 Comparing impact of biologic DMARDs, Jak inhibitor, and conventional DMARDs on lipid profile and atherogenic index of plasma in RA patients Hong Ki Min(Konkuk Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 14:15~14:30 Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO registry Jung Hee Koh(The Catholic Univ. of Korea Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 14:30~14:45 Predictors of disease flare in rheumatoid arthritis patients with low disease activity Ki Won Moon(Kangwon Nat'l Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM B 14:45~15:00 Effect of smoking and obesity on disease activity of patients with early rheumatoid arthritis: Data from the KORONA registry Min Kyung Chung(Ewha Womans Univ. Korea)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM C 08:00~08:50 Long term value of Etanercept to manage Juvenile Rheumatic Disease Earl D. Silverman(Univ. of Toronto Canada)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM C 11:00~12:30 Free Paper Session – Systemic Lupus Erythematosus ±¸¿¬(¹ßÇ¥ ¼¼¼Ç)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM C 12:30~13:30 Challenge treatment goal in RA and Raise expectations with Upadacitinib Andrew Ostor(Cabrini Medical Center Australia)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM C 13:30~15:00 Free Paper Session - Sjögren¡¯s Syndrome and Systemic Sclerosis ±¸¿¬(¹ßÇ¥ ¼¼¼Ç)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM C 15:30~16:30 ¼º¼Ò¼öÀÚÀÇ ºñº´¸®È Depathologization for LGBTI people ¹ÚÇÑÈñ Han-Hee Park(°øÀÍÀαǺ¯È£»ç¸ðÀÓ Èñ¸ÁÀ»¸¸µå´Â¹ý Korean Lawyers for Public Interest and Human Rights)
±³À°½Ã°£ 10¿ù 22ÀÏ ROOM C 16:30~17:30 Çѱ¹¿¡¼ ¿©¼ºÁÖÀÇ ÀÇ·á ½Çõ Feminist medicine in Korea ÃßÇýÀÎ Hyein Chu(»ì¸²ÀǷẹÁö»çȸÀûÇùµ¿Á¶ÇÕ Salim health & Welfare Cooperative)